Publication | Closed Access
Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland
60
Citations
13
References
2010
Year
Patients who initiate natalizumab after previous high disease activity experience a marked reduction of clinical and MRI disease activity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1